NEU 2.99% $20.10 neuren pharmaceuticals limited

Medium term milestones, page-13

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735

    Certainly dependent on the outcome of their trial a negative outcome would have a short term material effect. However, a positive outcome in theory may have an effect but practically speaking it took Neuren nearly 18 months between release of phase III data to launch date. So before any impact, we will be well established and advanced, at least 18 to 24 months down the track. A time period that will likely see significant company changing events occur.
    That’s also assuming the FDA accepts that their positive results are indeed positive results

    Last edited by goldenchook: 04/09/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.